Andere Sprachen HeartBeam, Inc.

Aktien

A3C7MX

US42238H1086

BEAT

Markt geschlossen - Nasdaq Andere Börsenplätze 22:30:00 15.05.2024			% 5 Tage	% 1. Jan.
2,15 ^USD	+4,37 %		+2,87 %	-8,51 %

09.05.	Transcript : HeartBeam, Inc., Q1 2024 Earnings Call, May 09, 2024
09.05.	HeartBeam, Inc. meldet Ergebnis für das erste Quartal zum 31. März 2024	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

HeartBeam AIMIGo Recognized for Digital Health Innovation in 8th Annual MedTech Breakthrough Awards Program	14.05.
HeartBeam AIMIGo™ Recognized for Digital Health Innovation in 8th Annual MedTech Breakthrough Awards Program	13.05.
HeartBeam Reports First Quarter 2024 Results	09.05.
HeartBeam, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09.05.
HeartBeam to Host First Quarter 2023 Results Conference Call on Thursday May 9, 2024 at 4:30 p.m. Eastern Time	25.04.
HeartBeam Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias	09.04.
HeartBeam, Inc. Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias	09.04.
HeartBeam : Fourth Quarter 2023 Earnings Conference Call Presentation	20.03.
HeartBeam, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	20.03.
HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results	20.03.
First Patients Enrolled in Pivotal Study Evaluating HeartBeam's AIMIGo System for synthesizing a 12-Lead ECG	15.03.
First Patients Enrolled in Pivotal Study Evaluating HeartBeam’s AIMIGo™ System for Synthesizing a 12-Lead ECG	14.03.
HeartBeam, Inc. Announces First Patients Enrolled in Pivotal Study Evaluating HeartBeam's AIMIGo System for Synthesizing A 12-Lead ECG	14.03.
HeartBeam Receives Two New US Patents for its Core Cardiac Monitoring Technology	07.03.
HeartBeam, Inc. Receives Two New US Patents for Its Core Cardiac Monitoring Technology	07.03.
HeartBeam to Host Fourth Quarter and Full Year 2023 Results Conference Call on Wednesday March 20, 2024 at 4:30 p.m. Eastern Time	05.03.
HeartBeam, Inc. Announces Retirement of Richard Brounstein as Chief Financial Officer	05.02.
HeartBeam Unveils AI Program Designed to Deliver Unprecedented Personalized Cardiac Insights	14.12.
HeartBeam, Inc. Unveils AI Program Designed to Deliver Unprecedented Personalized Cardiac Insights	14.12.
HeartBeam, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen HeartBeam, Inc.

Aktien

A3C7MX

US42238H1086

BEAT

Andere Sprachen

Filter